Home The Big Story Remedying A Monopolistic Ad Server

Remedying A Monopolistic Ad Server

SHARE:
Logo for AdExchanger's Big Story podcast, with journalistic insights on advertising, marketing and ad tech

The witness list for the remedy phase of the Google antitrust trial is out, and it offers some clues as to what the Justice Department will seek in terms of remedies.

To refresh, Google was ruled a monopoly in April, after a trial the previous fall. Now, Judge Brinkema needs to determine what can be done to undo that monopoly. Some of the witnesses who may testify are new to the Alexandria, Virginia, courthouse guest list, while others will be repeat guests when the remedy phase starts on Monday, September 22.

The witnesses include a mix of representatives from companies harmed by Google’s monopolistic practices. There will be publishers, SSPs and ad servers speaking at the trial, along with The Trade Desk, Google’s main buy-side rival.

On this week’s podcast, we go through the lineup of witnesses and explore Google’s code-named projects listed as exhibits, the old (Project Poirot) and the new (Project Grumpy).

The possible remedies span structural changes (e.g., spinning off its DFP ad server or AdX exchange) and behavioral changes (e.g., Google promising not to favor itself). While Google will argue for weaker behavioral changes, the DOJ will seek stronger structural changes.

One of the biggest changes would be a spinoff or forced divestiture of parts of Google’s ad tech business. While possible, smaller changes, such as giving rivals real-time access to bidding data from AdX, opening up DFP to outsiders, the open-sourcing of Google’s AdX auction logic or measures that would increase data transparency for publishers and other SSPs, could be easier to push through.

“The DOJ is asking for a lot,” Managing Editor Allison Schiff says. “It’s the kitchen sink. But why not?”

 

Must Read

Stagwell Acquires Publisher Monetization Network Freestar

The deal is the latest sign that media buyers are moving closer to publishers to shorten supply paths and get at the audience data they need to train AI agents.

The Healthcare Marketing Tech Company OptimizeRx Is Going Programmatic

OptimizeRx, which has software that plugs into the systems doctors use to prescribe drugs and maintain patient records, has taken its next big step into the world of programmatic through a new partnership with The Trade Desk.

Single continuous line drawing robot riding pencil rocket flying in the sky. Tech education and creativity. Future technology development. Artificial intelligence. One line design vector illustration

Q3: Omnicom’s Media Business Is Growing, But Is It Agent-Proof?

If AI agents can plan and buy media, who needs a holding company? Good question. It came up during Omnicom’s Q3 earnings on Thursday.

Privacy! Commerce! Connected TV! Read all about it. Subscribe to AdExchanger Newsletters

Netflix Touts New Measurement Capabilities As It Struggles With “Modest” Engagement Growth

Netflix’s revenue grew 12% YOY to $12.9 billion in Q3, which it maintains is in line with its forecast. Its ads business, however, is lagging slightly compared with expectations, causing Netflix to tweak its forecast for the rest of the year.

Apple Publishes Its Plan To Wipe Out Web Tracking

Apple is coming for identity resolution. WebKit’s latest tracking crackdown targets the infrastructure behind post-cookie IDs – and switching to a first-party setup won’t necessarily spare vendors.

AI Slop Sites Are On The Rise. Is Ad Tech Ready For Its New MFA Challenge?

Advertising supply chain intelligence company DecryptAds uncovered more than 2,100 AI-generated recipe sites that are monetized with programmatic ads and feature fabricated author profiles.